New hope drug trial for tough pancreatic cancer halted Mid-Study
NCT ID NCT03417921
Summary
This study tested whether adding an experimental drug called ABTL0812 to standard chemotherapy could better control advanced pancreatic cancer that has spread. It involved 60 adults newly diagnosed with metastatic pancreatic cancer who had not yet received treatment for it. The trial was suspended before completion, so results are not yet available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Marc Cortal
Barcelona, 08190, Spain
Conditions
Explore the condition pages connected to this study.